News
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.
All told, who took GLP-1 receptor agonists had a 7% lower risk of developing an OAC – which include cancers of the oesophagus, colon, rectum, stomach, liver, gallbladder, pancreas, kidney, post ...
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.
Officials say common weight loss and diabetes management drugs, known as GLP-1 receptor agonists, have become very popular nationwide, sold as Mounjaro, Zepbound, Ozempic, and Wegovy.
Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results